sodium channel, voltage-gated, type II, beta |
ITRACONAZOLE |
Sodium Channel, Site 2 |
92% |
2.577uM |
2.351uM |
View
|
sodium channel, voltage-gated, type II, alpha 2 |
ITRACONAZOLE |
Sodium Channel, Site 2 |
92% |
2.577uM |
2.351uM |
View
|
sodium channel, voltage-gated, type I, beta |
ITRACONAZOLE |
Sodium Channel, Site 2 |
92% |
2.577uM |
2.351uM |
View
|
sodium channel, voltage-gated, type I, alpha |
ITRACONAZOLE |
Sodium Channel, Site 2 |
92% |
2.577uM |
2.351uM |
View
|
sodium channel, voltage-gated, type IV, beta |
ITRACONAZOLE |
Sodium Channel, Site 2 |
92% |
2.577uM |
2.351uM |
View
|
sodium channel associated protein 1 |
ITRACONAZOLE |
Sodium Channel, Site 2 |
92% |
2.577uM |
2.351uM |
View
|
sodium channel associated protein 2 |
ITRACONAZOLE |
Sodium Channel, Site 2 |
92% |
2.577uM |
2.351uM |
View
|
sodium channel, voltage-gated, type III, beta |
ITRACONAZOLE |
Sodium Channel, Site 2 |
92% |
2.577uM |
2.351uM |
View
|
sodium channel, voltage-gated, type I, alpha |
ITRACONAZOLE |
Sodium Channel, Site 2 |
92% |
2.577uM |
2.351uM |
View
|
sodium channel, voltage-gated, type IX, alpha |
ITRACONAZOLE |
Sodium Channel, Site 2 |
92% |
2.577uM |
2.351uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
N,N'-DIPHENYL-P-PHENYLENEDIAMINE |
Serotonin 5-HT2B |
92% |
.142uM |
.09uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
PROPRANOLOL |
Serotonin 5-HT2B |
92% |
.342uM |
.218uM |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
KETAMINE |
Glutamate, NMDA, Phencyclidine |
92% |
1.01uM |
.684uM |
View
|
glutamate receptor, ionotropic, NMDA2C |
KETAMINE |
Glutamate, NMDA, Phencyclidine |
92% |
1.01uM |
.684uM |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
KETAMINE |
Glutamate, NMDA, Phencyclidine |
92% |
1.01uM |
.684uM |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
KETAMINE |
Glutamate, NMDA, Phencyclidine |
92% |
1.01uM |
.684uM |
View
|
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) |
KETAMINE |
Glutamate, NMDA, Phencyclidine |
92% |
1.01uM |
.684uM |
View
|
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
KETAMINE |
Glutamate, NMDA, Phencyclidine |
92% |
1.01uM |
.684uM |
View
|
adrenergic receptor, beta 3 |
BOPINDOLOL |
Adrenergic beta3 |
92% |
.458uM |
.344uM |
View
|
nuclear receptor subfamily 3, group C, member 1 |
CYPROTERONE ACETATE |
Glucocorticoid |
92% |
.225uM |
.102uM |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
RESERPINE |
Calcium Channel Type L, Dihydropyridine |
92% |
.821uM |
.528uM |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
RESERPINE |
Calcium Channel Type L, Dihydropyridine |
92% |
.821uM |
.528uM |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
RESERPINE |
Calcium Channel Type L, Dihydropyridine |
92% |
.821uM |
.528uM |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
RESERPINE |
Calcium Channel Type L, Dihydropyridine |
92% |
.821uM |
.528uM |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
RESERPINE |
Calcium Channel Type L, Dihydropyridine |
92% |
.821uM |
.528uM |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
RESERPINE |
Calcium Channel Type L, Dihydropyridine |
92% |
.821uM |
.528uM |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
RESERPINE |
Calcium Channel Type L, Dihydropyridine |
92% |
.821uM |
.528uM |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
RESERPINE |
Calcium Channel Type L, Dihydropyridine |
92% |
.821uM |
.528uM |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
RESERPINE |
Calcium Channel Type L, Dihydropyridine |
92% |
.821uM |
.528uM |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
RESERPINE |
Calcium Channel Type L, Dihydropyridine |
92% |
.821uM |
.528uM |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
RESERPINE |
Calcium Channel Type L, Dihydropyridine |
92% |
.821uM |
.528uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
RESERPINE |
Calcium Channel Type L, Dihydropyridine |
92% |
.821uM |
.528uM |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
RESERPINE |
Calcium Channel Type L, Dihydropyridine |
92% |
.821uM |
.528uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
RESERPINE |
Calcium Channel Type L, Dihydropyridine |
92% |
.821uM |
.528uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
RESERPINE |
Calcium Channel Type L, Dihydropyridine |
92% |
.821uM |
.528uM |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
RESERPINE |
Calcium Channel Type L, Dihydropyridine |
92% |
.821uM |
.528uM |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
RESERPINE |
Calcium Channel Type L, Dihydropyridine |
92% |
.821uM |
.528uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
RESERPINE |
Calcium Channel Type L, Dihydropyridine |
92% |
.821uM |
.528uM |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
RESERPINE |
Calcium Channel Type L, Dihydropyridine |
92% |
.821uM |
.528uM |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
RESERPINE |
Calcium Channel Type L, Dihydropyridine |
92% |
.821uM |
.528uM |
View
|
adrenergic receptor, alpha 1d (Non-specific probe) |
OLANZAPINE |
Adrenergic alpha1D |
92% |
.092uM |
.045uM |
View
|
dopamine receptor 2 |
OLANZAPINE |
Dopamine D2L |
92% |
.118uM |
.039uM |
View
|
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
OXICONAZOLE |
Adrenergic, Norepinephrine Transporter |
92% |
1.9103uM |
1.8945uM |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
EBASTINE |
Calcium Channel Type L, Dihydropyridine |
92% |
.1436uM |
.0923uM |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
EBASTINE |
Calcium Channel Type L, Dihydropyridine |
92% |
.1436uM |
.0923uM |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
EBASTINE |
Calcium Channel Type L, Dihydropyridine |
92% |
.1436uM |
.0923uM |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
EBASTINE |
Calcium Channel Type L, Dihydropyridine |
92% |
.1436uM |
.0923uM |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
EBASTINE |
Calcium Channel Type L, Dihydropyridine |
92% |
.1436uM |
.0923uM |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
EBASTINE |
Calcium Channel Type L, Dihydropyridine |
92% |
.1436uM |
.0923uM |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
EBASTINE |
Calcium Channel Type L, Dihydropyridine |
92% |
.1436uM |
.0923uM |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
EBASTINE |
Calcium Channel Type L, Dihydropyridine |
92% |
.1436uM |
.0923uM |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
EBASTINE |
Calcium Channel Type L, Dihydropyridine |
92% |
.1436uM |
.0923uM |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
EBASTINE |
Calcium Channel Type L, Dihydropyridine |
92% |
.1436uM |
.0923uM |
View
|
sodium channel, voltage-gated, type III, beta |
ITRACONAZOLE |
Sodium Channel, Site 2 |
92% |
2.577uM |
2.351uM |
View
|
sodium channel, voltage-gated, type VIII, alpha polypeptide |
ITRACONAZOLE |
Sodium Channel, Site 2 |
92% |
2.577uM |
2.351uM |
View
|
sodium channel, voltage-gated, type XI, alpha |
ITRACONAZOLE |
Sodium Channel, Site 2 |
92% |
2.577uM |
2.351uM |
View
|
sodium channel, voltage-gated, type I, beta |
ITRACONAZOLE |
Sodium Channel, Site 2 |
92% |
2.577uM |
2.351uM |
View
|
sodium channel, voltage-gated, type 10, alpha polypeptide |
ITRACONAZOLE |
Sodium Channel, Site 2 |
92% |
2.577uM |
2.351uM |
View
|
sodium channel, voltage-gated, type IV, alpha polypeptide |
ITRACONAZOLE |
Sodium Channel, Site 2 |
92% |
2.577uM |
2.351uM |
View
|
sodium channel, voltage-gated, type V, alpha polypeptide |
ITRACONAZOLE |
Sodium Channel, Site 2 |
92% |
2.577uM |
2.351uM |
View
|
sodium channel, voltage-gated, type II, beta |
ITRACONAZOLE |
Sodium Channel, Site 2 |
92% |
2.577uM |
2.351uM |
View
|
sodium channel, nonvoltage-gated 1 alpha |
ITRACONAZOLE |
Sodium Channel, Site 2 |
92% |
2.577uM |
2.351uM |
View
|
sodium channel, nonvoltage-gated 1 gamma |
ITRACONAZOLE |
Sodium Channel, Site 2 |
92% |
2.577uM |
2.351uM |
View
|
sodium channel, nonvoltage-gated 1 beta |
ITRACONAZOLE |
Sodium Channel, Site 2 |
92% |
2.577uM |
2.351uM |
View
|
sodium channel, voltage-gated, type 2, alpha 1 polypeptide |
ITRACONAZOLE |
Sodium Channel, Site 2 |
92% |
2.577uM |
2.351uM |
View
|
sodium channel, voltage-gated, type XI, alpha |
ITRACONAZOLE |
Sodium Channel, Site 2 |
92% |
2.577uM |
2.351uM |
View
|
sodium channel, nonvoltage-gated 1, gamma |
ITRACONAZOLE |
Sodium Channel, Site 2 |
92% |
2.577uM |
2.351uM |
View
|
sodium channel, nonvoltage-gated 1, delta |
ITRACONAZOLE |
Sodium Channel, Site 2 |
92% |
2.577uM |
2.351uM |
View
|
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) |
ITRACONAZOLE |
Sodium Channel, Site 2 |
92% |
2.577uM |
2.351uM |
View
|
sodium channel, nonvoltage-gated 1 alpha |
ITRACONAZOLE |
Sodium Channel, Site 2 |
92% |
2.577uM |
2.351uM |
View
|
sodium channel, voltage-gated, type X, alpha |
ITRACONAZOLE |
Sodium Channel, Site 2 |
92% |
2.577uM |
2.351uM |
View
|
sodium channel, voltage-gated, type IX, alpha |
ITRACONAZOLE |
Sodium Channel, Site 2 |
92% |
2.577uM |
2.351uM |
View
|
sodium channel, voltage gated, type VIII, alpha |
ITRACONAZOLE |
Sodium Channel, Site 2 |
92% |
2.577uM |
2.351uM |
View
|
sodium channel, voltage-gated, type VII, alpha |
ITRACONAZOLE |
Sodium Channel, Site 2 |
92% |
2.577uM |
2.351uM |
View
|
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
KETOCONAZOLE |
Serotonin Transporter |
92% |
.531uM |
.282uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2C |
DEXCHLORPHENIRAMINE |
Serotonin 5-HT2C |
92% |
2.322uM |
1.217uM |
View
|
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
DEXCHLORPHENIRAMINE |
Dopamine Transporter |
92% |
.931uM |
.739uM |
View
|
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
CIGLITAZONE |
Serotonin Transporter |
92% |
14.948uM |
7.941uM |
View
|
dopamine receptor D1A |
ERGOCORNINE |
Dopamine D1 |
92% |
.294uM |
.147uM |
View
|
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
SULCONAZOLE |
Dopamine Transporter |
92% |
1.726uM |
1.371uM |
View
|
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
DANAZOL |
Adrenergic, Norepinephrine Transporter |
92% |
5.698uM |
5.651uM |
View
|
dopamine receptor D1A |
DIETHYLSTILBESTROL |
Dopamine D1 |
92% |
7.763uM |
3.882uM |
View
|
mu-opioid receptor MOR |
MIFEPRISTONE |
Opiate mu |
92% |
2.457uM |
.997uM |
View
|
adrenergic receptor, alpha 1d (Non-specific probe) |
EPINEPHRINE |
Adrenergic alpha1D |
92% |
.449uM |
.221uM |
View
|
prostaglandin-endoperoxide synthase 2 |
4-OCTYLPHENOL |
Cyclooxygenase COX-2 |
92% |
2.862uM |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
4-OCTYLPHENOL |
Cyclooxygenase COX-2 |
92% |
2.862uM |
NoneNone |
View
|
epidermal growth factor receptor |
PYROGALLOL |
Protein Tyrosine Kinase, EGF Receptor |
92% |
1.23uM |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
CELECOXIB |
Serotonin Transporter |
92% |
6.276uM |
3.334uM |
View
|
phosphodiesterase 5A, cGMP-specific |
ALPHA-NAPHTHOFLAVONE |
Phosphodiesterase PDE5 |
92% |
2.3034uM |
NoneNone |
View
|
phosphodiesterase 5A, cGMP-specific |
ALPHA-NAPHTHOFLAVONE |
Phosphodiesterase PDE5 |
92% |
2.3034uM |
NoneNone |
View
|
thromboxane A synthase 1 |
CLOTRIMAZOLE |
Thromboxane Synthetase |
92% |
.014uM |
NoneNone |
View
|
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
CLOTRIMAZOLE |
Thromboxane Synthetase |
92% |
.014uM |
NoneNone |
View
|
mitogen activated protein kinase 1 |
TRETINOIN |
Protein Serine/Threonine Kinase, ERK2 |
92% |
.576uM |
NoneNone |
View
|
mitogen-activated protein kinase 1 |
TRETINOIN |
Protein Serine/Threonine Kinase, ERK2 |
92% |
.576uM |
NoneNone |
View
|
cholinergic receptor, muscarinic 4 |
BETAMETHASONE PHOSPHATE |
Muscarinic M4 |
92% |
11.924uM |
1.663uM |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
TAMOXIFEN |
Calcium Channel Type L, Phenylalkylamine |
92% |
2.042uM |
1.985uM |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
TAMOXIFEN |
Calcium Channel Type L, Phenylalkylamine |
92% |
2.042uM |
1.985uM |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
TAMOXIFEN |
Calcium Channel Type L, Phenylalkylamine |
92% |
2.042uM |
1.985uM |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
TAMOXIFEN |
Calcium Channel Type L, Phenylalkylamine |
92% |
2.042uM |
1.985uM |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
TAMOXIFEN |
Calcium Channel Type L, Phenylalkylamine |
92% |
2.042uM |
1.985uM |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
TAMOXIFEN |
Calcium Channel Type L, Phenylalkylamine |
92% |
2.042uM |
1.985uM |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
TAMOXIFEN |
Calcium Channel Type L, Phenylalkylamine |
92% |
2.042uM |
1.985uM |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
TAMOXIFEN |
Calcium Channel Type L, Phenylalkylamine |
92% |
2.042uM |
1.985uM |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
EBASTINE |
Calcium Channel Type L, Dihydropyridine |
92% |
.1436uM |
.0923uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
EBASTINE |
Calcium Channel Type L, Dihydropyridine |
92% |
.1436uM |
.0923uM |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
EBASTINE |
Calcium Channel Type L, Dihydropyridine |
92% |
.1436uM |
.0923uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
EBASTINE |
Calcium Channel Type L, Dihydropyridine |
92% |
.1436uM |
.0923uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
EBASTINE |
Calcium Channel Type L, Dihydropyridine |
92% |
.1436uM |
.0923uM |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
EBASTINE |
Calcium Channel Type L, Dihydropyridine |
92% |
.1436uM |
.0923uM |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
EBASTINE |
Calcium Channel Type L, Dihydropyridine |
92% |
.1436uM |
.0923uM |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
DICYCLOMINE |
Calcium Channel Type L, Phenylalkylamine |
92% |
.11uM |
.107uM |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
DICYCLOMINE |
Calcium Channel Type L, Phenylalkylamine |
92% |
.11uM |
.107uM |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
DICYCLOMINE |
Calcium Channel Type L, Phenylalkylamine |
92% |
.11uM |
.107uM |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
DICYCLOMINE |
Calcium Channel Type L, Phenylalkylamine |
92% |
.11uM |
.107uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
DICYCLOMINE |
Calcium Channel Type L, Phenylalkylamine |
92% |
.11uM |
.107uM |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
DICYCLOMINE |
Calcium Channel Type L, Phenylalkylamine |
92% |
.11uM |
.107uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
DICYCLOMINE |
Calcium Channel Type L, Phenylalkylamine |
92% |
.11uM |
.107uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
DICYCLOMINE |
Calcium Channel Type L, Phenylalkylamine |
92% |
.11uM |
.107uM |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
DICYCLOMINE |
Calcium Channel Type L, Phenylalkylamine |
92% |
.11uM |
.107uM |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
DICYCLOMINE |
Calcium Channel Type L, Phenylalkylamine |
92% |
.11uM |
.107uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
DICYCLOMINE |
Calcium Channel Type L, Phenylalkylamine |
92% |
.11uM |
.107uM |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
DICYCLOMINE |
Calcium Channel Type L, Phenylalkylamine |
92% |
.11uM |
.107uM |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
DICYCLOMINE |
Calcium Channel Type L, Phenylalkylamine |
92% |
.11uM |
.107uM |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
DICYCLOMINE |
Calcium Channel Type L, Phenylalkylamine |
92% |
.11uM |
.107uM |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
DICYCLOMINE |
Calcium Channel Type L, Phenylalkylamine |
92% |
.11uM |
.107uM |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
DICYCLOMINE |
Calcium Channel Type L, Phenylalkylamine |
92% |
.11uM |
.107uM |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
DICYCLOMINE |
Calcium Channel Type L, Phenylalkylamine |
92% |
.11uM |
.107uM |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
DICYCLOMINE |
Calcium Channel Type L, Phenylalkylamine |
92% |
.11uM |
.107uM |
View
|
prostaglandin-endoperoxide synthase 1 |
ASPIRIN |
Cyclooxygenase COX-1 |
92% |
4.192uM |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
ASPIRIN |
Cyclooxygenase COX-1 |
92% |
4.192uM |
NoneNone |
View
|
progesterone receptor |
FLURANDRENOLIDE |
Progesterone |
92% |
.172uM |
.022uM |
View
|
progesterone receptor |
FLURANDRENOLIDE |
Progesterone |
92% |
.172uM |
.022uM |
View
|
opioid receptor, sigma 1 |
TICLOPIDINE |
Sigma1 |
92% |
.426uM |
.179uM |
View
|
prostaglandin-endoperoxide synthase 1 |
FLURBIPROFEN |
Cyclooxygenase COX-1 |
92% |
.021uM |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
FLURBIPROFEN |
Cyclooxygenase COX-1 |
92% |
.021uM |
NoneNone |
View
|
adrenergic receptor, alpha 2a |
TICLOPIDINE |
Adrenergic alpha2A |
92% |
.382uM |
.143uM |
View
|
prostaglandin-endoperoxide synthase 2 |
SULINDAC SULFIDE |
Cyclooxygenase COX-2 |
92% |
1.537uM |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
SULINDAC SULFIDE |
Cyclooxygenase COX-2 |
92% |
1.537uM |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
R-(+)-PROPRANOLOL |
Serotonin Transporter |
92% |
.612uM |
.325uM |
View
|
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
GENTIAN VIOLET |
Dopamine Transporter |
92% |
4.069uM |
3.233uM |
View
|
dopamine receptor D1A |
MIANSERIN |
Dopamine D1 |
92% |
.543uM |
.271uM |
View
|
adrenergic receptor, alpha 2a |
MIANSERIN |
Imidazoline I2, Central |
92% |
.124uM |
.083uM |
View
|
adrenergic receptor, alpha 2c (Non-specific probe) |
MIANSERIN |
Imidazoline I2, Central |
92% |
.124uM |
.083uM |
View
|
tachykinin receptor 2 |
INDINAVIR |
Tachykinin NK2 |
92% |
5.101uM |
1.7uM |
View
|
dopamine receptor 2 |
LYSERGOL |
Dopamine D2L |
92% |
.702uM |
.234uM |
View
|
adrenergic receptor, alpha 1b |
LOPERAMIDE |
Adrenergic alpha1B |
92% |
.965uM |
.534uM |
View
|
histamine receptor H 1 |
LORATADINE |
Histamine H1, Central |
92% |
.17uM |
.02uM |
View
|
adenosine A1 receptor |
RWJ-68354 |
Adenosine A1 |
92% |
.887uM |
.518uM |
View
|
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
RWJ-68354 |
Adrenergic, Norepinephrine Transporter |
92% |
1.07uM |
1.061uM |
View
|
5-hydroxytryptamine (serotonin) receptor 1A |
RISPERIDONE |
Serotonin 5-HT1A |
92% |
.799uM |
.457uM |
View
|
dopamine receptor D1A |
RISPERIDONE |
Dopamine D1 |
92% |
.479uM |
.24uM |
View
|
sodium channel, voltage-gated, type VII, alpha |
ITRACONAZOLE |
Sodium Channel, Site 2 |
92% |
2.577uM |
2.351uM |
View
|
amiloride-sensitive cation channel 5, intestinal |
ITRACONAZOLE |
Sodium Channel, Site 2 |
92% |
2.577uM |
2.351uM |
View
|
angiotensin 1 converting enzyme 1 |
CAPTOPRIL |
Protease, Angiotensin Converting Enzyme |
93% |
.13uM |
NoneNone |
View
|
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
CAPTOPRIL |
Protease, Angiotensin Converting Enzyme |
93% |
.13uM |
NoneNone |
View
|
mitogen activated protein kinase 14 |
TIRILAZAD |
Protein Serine/Threonine Kinase, p38alpha |
93% |
7.406uM |
NoneNone |
View
|
mitogen-activated protein kinase 14 |
TIRILAZAD |
Protein Serine/Threonine Kinase, p38alpha |
93% |
7.406uM |
NoneNone |
View
|
Protein-tyrosine kinase, Fyn |
2-HYDROXYPROPYL-BETA-CYCLODEXTRIN |
Protein Tyrosine Kinase, Fyn |
93% |
3.043uM |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
U-78517F |
Calcium Channel Type L, Benzothiazepine |
93% |
1.65uM |
1.466uM |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
U-78517F |
Calcium Channel Type L, Benzothiazepine |
93% |
1.65uM |
1.466uM |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
U-78517F |
Calcium Channel Type L, Benzothiazepine |
93% |
1.65uM |
1.466uM |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
U-78517F |
Calcium Channel Type L, Benzothiazepine |
93% |
1.65uM |
1.466uM |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
U-78517F |
Calcium Channel Type L, Benzothiazepine |
93% |
1.65uM |
1.466uM |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
U-78517F |
Calcium Channel Type L, Benzothiazepine |
93% |
1.65uM |
1.466uM |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
U-78517F |
Calcium Channel Type L, Benzothiazepine |
93% |
1.65uM |
1.466uM |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
U-78517F |
Calcium Channel Type L, Benzothiazepine |
93% |
1.65uM |
1.466uM |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
U-78517F |
Calcium Channel Type L, Benzothiazepine |
93% |
1.65uM |
1.466uM |
View
|
potassium voltage-gated channel, subfamily H, member 8 |
THIORIDAZINE |
Potassium Channel HERG |
93% |
1.588uM |
1.301uM |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 6 |
THIORIDAZINE |
Potassium Channel HERG |
93% |
1.588uM |
1.301uM |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 7 |
THIORIDAZINE |
Potassium Channel HERG |
93% |
1.588uM |
1.301uM |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
THIORIDAZINE |
Potassium Channel HERG |
93% |
1.588uM |
1.301uM |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 5 |
THIORIDAZINE |
Potassium Channel HERG |
93% |
1.588uM |
1.301uM |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 3 |
THIORIDAZINE |
Potassium Channel HERG |
93% |
1.588uM |
1.301uM |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 4 |
THIORIDAZINE |
Potassium Channel HERG |
93% |
1.588uM |
1.301uM |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 1 |
THIORIDAZINE |
Potassium Channel HERG |
93% |
1.588uM |
1.301uM |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 1 |
THIORIDAZINE |
Potassium Channel HERG |
93% |
1.588uM |
1.301uM |
View
|
Cytochrom P450-2D6 monooxygenase |
BW-723C86 |
CYP450-2D6 Inhibition |
93% |
2.7743uM |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
SULOCTIDIL |
Serotonin Transporter |
93% |
1.2532uM |
.6658uM |
View
|
epidermal growth factor receptor |
SULOCTIDIL |
Protein Tyrosine Kinase, EGF Receptor |
93% |
.7944uM |
NoneNone |
View
|
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
GLYBURIDE |
CYP450-2C9 Inhibition |
93% |
1.602uM |
NoneNone |
View
|
cytochrome P450, family 2, subfamily C, polypeptide 9 |
GLYBURIDE |
CYP450-2C9 Inhibition |
93% |
1.602uM |
NoneNone |
View
|
androgen receptor |
HYDROXYPROGESTERONE |
Testosterone |
93% |
.739uM |
.493uM |
View
|
opioid receptor, sigma 1 |
TOLPERISONE |
Sigma1 |
93% |
.013uM |
.005587uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2A |
CINNARIZINE |
Serotonin 5-HT2A |
93% |
.36uM |
.103uM |
View
|
5-hydroxytryptamine (serotonin) receptor 1A |
THIORIDAZINE |
Serotonin 5-HT1A |
93% |
.06uM |
.034uM |
View
|
glycine receptor, alpha 3 |
DESLORATADINE |
Glycine, Strychnine-Sensitive |
93% |
.834uM |
.471uM |
View
|
glycine receptor, alpha 1 subunit |
DESLORATADINE |
Glycine, Strychnine-Sensitive |
93% |
.834uM |
.471uM |
View
|
glycine receptor, beta subunit |
DESLORATADINE |
Glycine, Strychnine-Sensitive |
93% |
.834uM |
.471uM |
View
|
glycine receptor, alpha 2 subunit |
DESLORATADINE |
Glycine, Strychnine-Sensitive |
93% |
.834uM |
.471uM |
View
|
dopamine receptor 2 |
CINNARIZINE |
Dopamine D2L |
93% |
.776uM |
.259uM |
View
|
Cytochrom P450-2D6 monooxygenase |
L-744832 |
CYP450-2D6 Inhibition |
93% |
.7uM |
NoneNone |
View
|
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
PODOPHYLLOTOXIN |
CYP450-2C9 Inhibition |
93% |
4uM |
NoneNone |
View
|
cytochrome P450, family 2, subfamily C, polypeptide 9 |
PODOPHYLLOTOXIN |
CYP450-2C9 Inhibition |
93% |
4uM |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
BITHIONOL |
Dopamine Transporter |
93% |
2.181uM |
1.733uM |
View
|
cholinergic receptor, muscarinic 2 |
DIPHENIDOL |
Muscarinic M2 |
93% |
.77uM |
.274uM |
View
|
androgen receptor |
ETHISTERONE |
Testosterone |
93% |
.067uM |
.044uM |
View
|
progesterone receptor |
ETHYLESTRENOL |
Progesterone |
93% |
.201uM |
.026uM |
View
|
progesterone receptor |
ETHYLESTRENOL |
Progesterone |
93% |
.201uM |
.026uM |
View
|
cholinergic receptor, muscarinic 2 |
ETHYLESTRENOL |
Muscarinic M2 |
93% |
.292uM |
.104uM |
View
|
adrenergic receptor, alpha 1a |
CLONIDINE |
Adrenergic alpha1A |
93% |
.372uM |
.151uM |
View
|